Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation
PHASE2CompletedINTERVENTIONAL
Timeline
Start Date
August 31, 1998
Study Completion Date
February 28, 2003
Conditions
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic TumorKidney CancerLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesNeuroblastomaOvarian CancerSarcomaTesticular Germ Cell Tumor
Interventions
BIOLOGICAL
peripheral blood lymphocyte therapy
Trial Locations (1)
98109
Fred Hutchinson Cancer Research Center, Seattle
All Listed Sponsors
collaborator
National Cancer Institute (NCI)
NIH
lead
Fred Hutchinson Cancer Center
OTHER
NCT00003887 - Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation | Biotech Hunter | Biotech Hunter